1. Anderson CJ, Dehdashti F, Cutler PD, Schwarz SW, Laforest R, Bass LA, Lewis JS, McCarthy DW (2001) 64Cu-TETA-octreo-tide as a PET imaging agent for patients with neuroendocrine tumors. J Nucl Med 42:213–221
2. Anderson MA, Carpenter S, Thompson NW, Nostrant TT, Elta GH, Scheiman JM. (2000) Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 95: 2271–2277
3. Aspestrand F, Kolmannskog F, Jacobsen M (1993) CT, MR imaging and angiography in pancreatic APUDomas. Acta Radiol 34:468–473
4. Bakker WH, Krenning EP, Breeman WA, Kooij PP, Reubi JC, Koper JW, de Jong M, Lameris JS, Visser TJ, Lamberts SW (1991) In vivo use of radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man. J Nuc Med 32: 1184–1189
5. Bansal R, Tierney W, Carpenter S, Thompson N, Scheiman JM. (1999) Cost effectiveness of EUS for preoperative localization of pancreatic endocrine tumors. Gastrointest Endosc 49:19–25